Gangestad Nicholas C 4
4 · Genpact LTD · Filed Apr 27, 2026
Research Summary
AI-generated summary of this filing
Genpact Director Nicholas C. Gangestad Receives RSU Award (6,521)
What Happened
- Nicholas C. Gangestad, a director of Genpact Ltd. (G), received an award of 6,521 restricted stock units (RSUs) on April 23, 2026. The grant price is reported as $0.00 (typical for RSU awards), so there was no cash paid at the time of grant. The reported dollar value at grant is $0 on the Form 4 entry itself.
Key Details
- Transaction date: 2026-04-23; Transaction code: A (award/grant/acquisition).
- Award size: 6,521 RSUs; reported acquisition price: $0.00.
- Vesting/settlement: RSUs fully vest on December 31, 2026 (subject to continued service) and will be settled in common shares on December 31, 2027 (per footnote).
- Shares owned after transaction: not specified in the filing.
- Timeliness: Filing dated 2026-04-27 for a 2026-04-23 grant — this is four days after the transaction and may exceed the standard two-business-day reporting window for insiders.
Context
- RSUs are a compensation award that convert to shares at vesting/settlement; they do not represent an immediate cash purchase or sale and are not an immediate market signal. Grants are common as part of executive/director pay packages; they differ from open-market purchases (which can suggest a bullish signal) or immediate sales.
Insider Transaction Report
Form 4
Gangestad Nicholas C
Director
Transactions
- Award
Common Shares
[F1]2026-04-23+6,521→ 15,334 total
Footnotes (1)
- [F1]Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Nicholas C. Gangestad|2026-04-27